Anergis Is A Clinical Stage Biopharmaceutical Company Based In Switzerland Anergis Discovers And Develops Proprietary Synthetic Allergy Vaccines With The Aim To Provide Allergy Patients And Doctors With A Significantly Improved Treatment Optionultra Fast Immunotherapy Anergis Cop Allergy Vaccines Are Pharmaceutical Grade Products Based On Contiguous Overlapping Peptidescopsand Only Need To Be Administered For 2 Months In Order To Achieve Long Lasting Desensitization Anergis Strives To Improve The Medical Treatment Of Patients Suffering From Allergies By Promoting A Shift In Treatment Paradigms From Short Term Symptomatic Relief To Long Term Cure From Allergies By Ultra Fast Desensitization If You Are Interested To Participate In One Of Our Clinical Trialsplease Send An Email To Info Anergis Ch
